Conflict of Interest Form from Disruption of &lt;i&gt;in vivo&lt;/i&gt; Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study